DMDoris Moser

Doris Moser

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Doris Moser has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris

    by Saskia Seiser, Helena Brezovec, Philipp Penninger, Trinh Phan-Canh, Doris Moser, Frank P. Assen, Tanya Ayub, Franziska Rademacher, Regine Gläser, Diana Cerbu, et al.


  • Open Access

    Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103

    by Trinh Phan-Canh, Cristina Coman, Michaela Lackner, Nina Troppmair, Christoph Müller, Diana Cerbu, Saskia Seiser, Philipp Penninger, Irina Tsymala, Narakorn Khunweeraphong, et al.

    The pronounced skin tropism and pan-antifungal resistance of Candida auris pose a serious global health threat. A key question in C. auris biology is how clinical isolates acquire amphotericin B resistance. Here we demonstrate that a carbonic sensing pathway (CSP) contributes to amphotericin B resistance by modulating mitochondrial energy functions in clinical C. auris isolates. Integrated transcriptomics and proteomics identify the carbonic anhydrase Nce103 and its transcription factors Rca1 and Efg1 as important regulatory components of the CSP. The conversion of CO 2 into bicarbonate sustains energy metabolism required for colonization and fitness on human skin and in nutrient-limited microenvironments. We also show that bacterial skin colonizers engage urease to release CO 2 that sustains C. auris fitness and skin colonization. These findings highlight therapeutic options to re-sensitize C. auris to antifungal treatments, as well as to prevent skin colonization by blocking the CSP.


  • Open Access

    Octenidine effectively reduces Candida auris colonisation on human skin

    by Diana Cerbu, Saskia Seiser, Trinh Phan-Canh, Doris Moser, Christian Freystätter, Johannes Matiasek, Karl Kuchler, Adelheid Elbe-Bürger

    Candidozyma (formerly Candida) auris (C. auris), a WHO critical priority pathogen known for its multi-drug resistance and strong skin tropism, is posing a significant health threat. This study evaluates the efficacy of commercial octenidine-based antiseptics in reducing C. auris colonisation on intact and wounded human skin. Using an established ex vivo human skin model to simulate clinical settings, skin samples from healthy donors were exposed to planktonic C. auris cells. Six hours post-contamination, two ready-to-use octenidine-based antiseptics were applied, and fungal colonisation was assessed after 18 h via periodic acid-Schiff staining, bright field and scanning electron microscopy and colony forming unit quantification. In vitro biofilm assays with various C. auris strains, including drug resistant ones, were performed to determine the antifungal effects of octenidine formulations. Results showed that octenidine-based antiseptics significantly reduced C. auris viability on intact and wounded human skin, and also demonstrated a nearly complete eradication across tested strains in vitro. These findings highlight the potential of octenidine-based products in reducing C. auris colonisation, supporting infection prevention and control strategies in healthcare settings and enhancing patient safety.


  • Open Access

    Carbon Dioxide Controls Fungal Fitness and Skin Tropism of Candida auris

    by Trinh Phan-Canh, Philipp Penninger, Saskia Seiser, Narakorn Khunweeraphong, Doris Moser, Tamires Bitencourt, Hossein Arzani, Weiqiang Chen, Lisa-Maria Zenz, Andrej Knarr, et al.

    The pronounced skin tropism and pan-antifungal resistance traits of the fungal pathogen Candida auris stand out as a serious health threat. Here, we show that a carbonic sensing pathway (CSP) promotes development of resistance to amphotericin B through a reactive oxygen species (ROS) response, as well as ectopic cell wall and membrane lipid homeostasis. Mechanistically, the transcription factor Rca1 acts in cooperation with Efg1 to control the expression and activity of the carbonic anhydrase Nce103 as a key effector component. The conversion of carbon dioxide to bicarbonate provides a direct link to energy metabolism, facilitating colonization and growth on skin tissues. Native mouse and human skin models unequivocally show that the CSP is essential for maintaining skin tropism as well as fungal fitness. Curiously, upon ablation of Rca1 and Efg1, C. auris debilitates efficient growth on native skin. Collectively, our findings highlight critical roles of the CSP in C. auris skin tropism and antifungal drug resistance. The work suggests therapeutic options for disrupting skin colonization and thus preventing infections. Highlights: ✓ Proteo-transcriptomics links a carbonic sensing pathway (CSP) to C. auris multidrug resistance ✓ The Nce103 carbonic anhydrase controls drug resistance as a key component of the CSP ✓ The transcription factors Rca1 and Efg1 control Nce103 and link CSP with C. auris skin tropism ✓ CSP acts through ectopic ROS response, cell wall architecture and membrane lipid function ✓ CSP is required for C. auris fitness and efficient growth and colonization of skin tissues Result contents: ✓ Integrated omics reveals multidrug-resistant mechanisms in C. auris ✓ CO 2 -sensing controls amphotericin B resistance (AMB R ) traits through Rca1 and Efg1 ✓ The carbonic anhydrase Nce103 governs susceptibility to amphotericin B ✓ The CSP influences AMB R by maintaining reactive oxygen species homeostasis ✓ The CSP controls AMB R via cell membrane and cell wall remodelling ✓ The CSP regulates fungal fitness through controlling energy metabolism ✓ C. auris requires the CSP for skin colonization


  • Open Access

    The effectiveness of surface disinfectants and a micellic H2O2 based water disinfectant on Candida auris

    by Beata Zatorska, Doris Moser, Magda Diab-Elschahawi, Julia Ebner, Luigi Segagni Lusignani, Elisabeth Presterl


  • Heparin-binding epidermal growth factor expression in KATO-III cells after Helicobacter pylori stimulation under the influence of strychnos Nux vomica and Calendula officinalis

    by Roland Hofbauer, Eva Pasching, Doris Moser, Michael Frass

    Introduction: Previous studies have shown the stimulating effect of Helicobacter pylori on the gene expression of heparin-binding epidermal growth factor (HB-EGF) using the gastric epithelial cell line KATO-III. Strychnos Nux vomica (Nux vomica) and Calendula officinalis are used in highly diluted form in homeopathic medicine to treat patients suffering from gastritis and gastric ulcers. Aim and method: To investigate the influence of Nux vomica and Calendula officinalis on HB-EGF-like growth factor gene expression in KATO-III cells under the stimulation of H. pylori strain N6 using real-time PCR with and without addition of Nux vomica and Calendula officinalis as a 10c or 12c potency. Results: Baseline expression and stimulation were similar to previous experiments, addition of Nux vomica 10c and Calendula officinalis 10c in a 43% ethanolic solution led to a significant reduction of H. pylori induced increase in gene expression of HB-EGF (reduced to 53.12 ± 0.95% and 75.32 ± 1.16% vs. control; p < 0.05), respectively. Nux vomica 12c reduced HB-EGF gene expression even in dilutions beyond Avogadro’s number (55.77 ± 1.09%; p < 0.05). Nux vomica 12c in a 21.5% ethanol showed a smaller effect (71.80 ± 3.91%, p < 0.05). This effect was only be observed when the drugs were primarily prepared in ethanol, not in aqueous solutions. The data suggest that both drugs prepared in ethanolic solution are potent inhibitors of H. pylori induced gene expression.